Is Linde plc Ordinary Shares (LIN) overvalued? · P/E 34, rev $33.99B
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
This page asks whether Linde plc Ordinary Shares (LIN) looks expensive on cached numbers — not a short thesis.
Latest reported LIN revenue for 2025-12-31 was $33.99B. Net income was $6.90B. Revenue was up 3.0% from 2024-12-31 to 2025-12-31. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
LIN currently screens at market cap $223.87B and trailing P/E 34.5. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next LIN 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the LIN stock page for the full model, not this heading.
Not investment advice.